Clinical Trials

A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

We need to face drug attrition to reduce the early-stage risk of drug development.

Are pharma companies willling to open up and share their clinical trial data?

Looking back on wise words from a year of Sitting Down With interviews.

Will AI generate new hypotheses and lead to repurposed failed drug candidates?

Can the microbiome predict the likelihood of chemotherapy side effects?

Drugs often fail , both before and after reaching the market - but why?

Boosting the body's built-in cannabinoid signaling receptors

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

Sitting Down With Elisa Cascade, President of Data Solutions at DrugDev